David R. Bailey is the CEO of OrthoPediatrics Corp., a company focused on improving healthcare for children with orthopedic conditions. He became CEO on June 3, 2021, after serving as President. Bailey joined OrthoPediatrics in 2007 when the company was...

David R. Bailey is the CEO of OrthoPediatrics Corp., a company focused on improving healthcare for children with orthopedic conditions. He became CEO on June 3, 2021, after serving as President. Bailey joined OrthoPediatrics in 2007 when the company was just starting out. He has had a big role in making the company what it is today, helping with everything from product development to building a global sales network. He studied Sales and Management at Purdue University and even took a leadership program at Harvard Business School. In 2023, his total compensation was $721,840, including a salary of $500,000 and a bonus for meeting performance targets. Under his leadership, the company has made strides in environmental, social, and governance (ESG) efforts. They support many charitable causes and strive to make a positive impact on the lives of children, showing that profit isn't the only goal. Besides work, Bailey has a business management background and is known for his hands-on approach in various key roles within the company.

Quick Links

1. Rivals

2. Holdings

3. Insider Trading

4. Compensation History

5. Other OrthoPediatrics CEOs

O

David R. Bailey

CEO of OrthoPediatrics

Education

Bachelor of Science in Sales and Sales Management from Purdue University

Field of Expertise

Sales & Marketing - Sales

Sector of Economy

Healthcare

Born

January 1, 1979 - 46 years ago

CEO of OrthoPediatrics for

4 years 0 months (Jun 2021 - Present)

Previous Experience

Sales Representative and Independent Distributor for Smith & Nephew Orthopaedics

Rivals

Competitors/colleagues of David R. Bailey

Holdings

See how much did David R. Bailey make over time.

David R. Bailey currently owns 144,897 shares in OrthoPediatrics, valued at around $139,384. His holdings have increased since he started as CEO. Over the years, he has steadily built up his shares through restricted stock units as compensation for his...

David R. Bailey currently owns 144,897 shares in OrthoPediatrics, valued at around $139,384. His holdings have increased since he started as CEO. Over the years, he has steadily built up his shares through restricted stock units as compensation for his role. In 2023, Bailey's holdings made up a small part of his total wealth compared to his significant salary and bonuses. His largest financial interaction with the company's stock occurred when he became CEO, which raised both his visibility and his stake in the company. This level of ownership shows his commitment to the company's success and aligns his personal wealth with the company's performance.

Total Stock Sold

$2.31M

KIDS

$2.31M

67,775 KIDS shares

What if they kept their stock?

If David R. Bailey didn't sell their stock, today they would have:
Extra KIDS67,775 shares worth $3.16M.
This is 36.92% and $852.95K more than what they got when they sold the stock.

Charitable Transactions

KIDS

22,486 shares

KIDS

Recent Charitable Transactions

KIDS

3,000 shares

KIDS

Dec 27, 2024

Charity

KIDS

2,300 shares

KIDS

Jul 28, 2023

Charity

KIDS

1,000 shares

KIDS

Dec 31, 2022

Charity

KIDS

1,000 shares

KIDS

Dec 29, 2021

Charity

KIDS

1,000 shares

KIDS

Dec 31, 2019

Charity

KIDS

14,186 shares

KIDS

Dec 31, 2018

Charity

Insider Trading

See recent insider trades of David R. Bailey.

KIDS

3,000 shares

KIDS

Dec 27, 2024

Charity

KIDS

90,395 shares

KIDS

Jun 11, 2024

Received

KIDS

$88.65K

KIDS at $27.59/share

Mar 11, 2024

Sale

KIDS

2,300 shares

KIDS

Jul 28, 2023

Charity

KIDS

44,444 shares

KIDS

Mar 15, 2023

Received

KIDS

$179.91K

KIDS at $44.40/share

Mar 6, 2023

Sale

KIDS

1,000 shares

KIDS

Dec 31, 2022

Charity

KIDS

15,091 shares

KIDS

Mar 15, 2022

Received

KIDS

$236.93K

KIDS at $58.10/share

Mar 2, 2022

Sale

KIDS

1,000 shares

KIDS

Dec 29, 2021

Charity

Compensation History

See how much did David R. Bailey make over time.

In 2023, David R. Bailey received a total compensation of $721,840 for his role as CEO of OrthoPediatrics. His base salary was $500,000. He also earned a bonus of $364,688 for achieving 97.5% of his annual performance goals, which focused on sales and EBITDA targets. Additionally, he received $144,874 from the vesting of stock units, showing a reliance on performance-based incentives instead of just fixed payments. In 2022, his compensation was higher at over $1.2 million, largely due to a bigger bonus reflecting a previous year's performance metrics. This pay strategy aims to keep leaders motivated and aligned with shareholders’ interests. Overall, his compensation reflects the company's growth and his hands-on role in driving its success.

Year

2023

Total Compensation

$2.32M

Salary

$500.00K

Board Justification

The compensation philosophy is designed to attract, motivate, reward, and retain senior management talent, aligning their interests with those of stockholders through performance-based incentives.

Bonus

$364.69K

Board Justification

The annual cash bonuses paid for performance in 2023 reflect achievement of 97.5% of the annual performance goals, based on specified sales, adjusted EBITDA, and Company objectives.

Other

$13.20K

Board Justification

Includes 401(k) matching contributions and other benefits.

Restricted Stock

$1.44M(44.44K RSU)

Board Justification

Restricted stock granted in 2023 that vested in 2023, with a total of 44,444 shares granted.

Performance Metrics

The performance metrics for the CEO's compensation in 2023 were based on specified sales, adjusted EBITDA, and Company objectives.

Other OrthoPediatrics CEOs

Here are other CEOs of OrthoPediatrics

Mark C. Throdahl

Ex-CEO of OrthoPediatrics

January 2011 - June 2021